Analyzing clear cell carcinoma of the cervix
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix - a Rare Tumor
This study looks at the medical records and tumor samples of patients with clear cell carcinoma of the cervix to better understand this type of cervical cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05046080 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with clear cell carcinoma of the cervix at M D Anderson Cancer Center. It aims to conduct a retrospective analysis of clinicopathologic features, immunohistochemical testing, and molecular profiling of the tumors. By reviewing medical records and analyzing archival tumor tissue through advanced techniques like next-generation sequencing, the study seeks to enhance understanding of this specific type of cervical cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have been diagnosed with clear cell carcinoma of the cervix at M D Anderson Cancer Center.
Not a fit: Patients with other types of cervical cancer or those who have not been treated at M D Anderson Cancer Center may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the molecular characteristics of clear cell carcinoma, potentially leading to improved diagnostic and therapeutic strategies.
How similar studies have performed: While this study is focused on a specific subtype of cervical cancer, similar studies have shown success in understanding other cancer types through comprehensive molecular profiling.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with clear cell carcinoma of the cervix at MDACC
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Anasis Malpica — M.D. Anderson Cancer Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.